Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Tumor Cell;”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07432308
What this trial is testing

Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Institute of Oncology Ljubljana 22
Not applicableUnknownNCT05371873
What this trial is testing

Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 250
Not applicableLooking for participantsNCT07059741
What this trial is testing

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University 20
Not applicableStudy completedNCT02370303
What this trial is testing

Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

Who this might be right for
Lung CancerLung NeoplasmsCancer of Lung+8 more
Mayo Clinic 23
Not applicableUnknownNCT05641870
What this trial is testing

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Who this might be right for
Lung CancerStage III Lung CancerUnresectable Lung Carcinoma
Parc de Salut Mar 80
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Not applicableUnknownNCT05816642
What this trial is testing

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
RenJi Hospital 500
Not applicableUnknownNCT03511859
What this trial is testing

Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics

Who this might be right for
Breast Cancer
CellMaxLife 210
Testing effectiveness (Phase 2)UnknownNCT03058809
What this trial is testing

Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood

Who this might be right for
Metastatic Cancer
Viatar LLC 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT07821333
What this trial is testing

Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III

Who this might be right for
Colorectal Neoplasms MalignantMinimal Residual DiseaseCirculating Tumor Cell
Fundación para la Investigación del Hospital Clínico de Valencia 45
Testing effectiveness (Phase 2)Study completedNCT02958852
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Lund University Hospital 126
Not applicableStudy completedNCT02246738
What this trial is testing

Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts

Who this might be right for
Urothelial Carcinoma of the Bladder
Abramson Cancer Center at Penn Medicine 87
Not applicableLooking for participantsNCT06672250
What this trial is testing

The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

Who this might be right for
Tumor Cells, CirculatingVenous Thrombosis
Chang Gung Memorial Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT00887640
What this trial is testing

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 11
Not applicableActive Not RecruitingNCT05814549
What this trial is testing

A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)

Who this might be right for
Oropharyngeal CancerHPV-Related CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Not applicableEnded earlyNCT04957602
What this trial is testing

Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)

Who this might be right for
Non Small Cell Lung Cancer
Hospices Civils de Lyon 6
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Large-scale testing (Phase 3)Study completedNCT01640405
What this trial is testing

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 350
Not applicableStudy completedNCT02339805
What this trial is testing

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

Who this might be right for
Non Hodgkin Lymphoma
Centre Henri Becquerel 30
Testing effectiveness (Phase 2)Looking for participantsNCT07183319
What this trial is testing

Circulating Tumor DNA Response In Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Oklahoma 30
Next Page